Stanford Blood CenterJune 16, 2010

FDA 483 - Stanford Blood Center - June 16, 2010

Record Details

The FDA inspected Stanford Medical School Blood Center in Palo Alto, CA, a blood bank. The inspection revealed significant issues related to the investigation of adverse reactions, specifically regarding a donor deferral. Additionally, the firm failed to submit multiple biological product deviation reports within the required timeframe.

Company: Stanford Blood Center
Inspection Date: June 16, 2010
Product Type: Biologics
Office: Division of Human and Animal Food Operations - West V
Person: Aneel K. Sandhu (Government Employee)

Open in Dashboard

ID · 9018f4b0-531f-4439-b5d6-3d0314a4d6ec